Bcl-2 antibody and the apoptosis reagent set that reports a decision, not a protein

Assembling the panel

1. Measure the balance, not one side of it. A survival protein rising means nothing without knowing what the sensitisers did. Blot at least one from each side on the same membrane, and report the ratio rather than the individual intensities.
2. Use cleaved substrate as the execution readout. A cleaved substrate is direct evidence that the machinery ran. Total substrate is a loading reference. Confusing the two is the most common misreading in this area, and reagents for both are sold under similar names.
3. Separate the two initiating routes. Receptor initiated and mitochondrial routes converge on the same executioners, so an executioner readout cannot tell you which fired. Blotting the two initiators, or blocking one, is what distinguishes them.
4. Collect the cells that detached. Dying cells lift off, and a lysate made from the adherent layer alone systematically under reports death. Collect the medium, spin it and add those cells back before lysis.
5. Confirm with an orthogonal readout. A surface stain, a fluorogenic activity assay or a viability count alongside the blot turns a suggestive band into a result. Two methods agreeing is what makes this class of experiment credible.

Death is a ratio, not a band

The decision to die is made by the balance between proteins that hold the mitochondrial membrane intact and proteins that permeabilise it. That is why a single measurement is uninformative and why panels in this area are bought as sets rather than as individual reagents.

Design the blot as a panel from the start: two survival proteins, two sensitisers, one initiator from each route and one cleaved substrate. It fits on one membrane with fluorescent multiplexing and answers far more than a series of single blots.

Timing decides what you see, and when a PARP 1 antibody reports cleavage

Cleaved products appear and are then degraded along with the cell. A single timepoint chosen for convenience routinely lands after the peak, which produces a negative result from a positive experiment.

Run one time course per cell type and treatment, choose the timepoint from it, and use that timepoint consistently. It is one experiment that makes everything after it interpretable.

An annexin v antibody and the stain that is not an antibody

Apoptosis is usually detected with labelled annexin V protein binding exposed phosphatidylserine, not with an antibody against annexin V, and the two are different products sold under similar names. An annexin v antibody detects the protein in a lysate or a section. Where the experiment is a flow cytometry apoptosis assay, the reagent needed is the labelled protein with a viability dye beside it.

A rip3 antibody and a ripk3 antibody name one kinase

The necroptosis kinase is listed under the short and the full gene symbol, so a rip3 antibody and a ripk3 antibody are often the same clone in two entries. The protein is expressed at low levels in many lines and is absent in some, which is the commonest reason a blot shows nothing. A line known to carry it belongs on the gel as the positive control.

A gsdmd antibody and the cleaved fragment that matters

Gasdermin D only forms pores after cleavage, so the readout is the appearance of the amino terminal fragment rather than the level of the full protein. A gsdmd antibody raised against the amino terminus shows both, while a neoepitope clone shows only the cleaved form. The figure has to say which, and an inflammasome activating treatment is the positive control that makes the fragment appear.

An mlkl antibody and the phosphorylation that commits the cell

MLKL is the executioner downstream of the necroptosis kinases and is activated by phosphorylation rather than by a change in level, so an mlkl antibody for total protein is the denominator and a phospho clone against the named residue is the measurement. The activated protein oligomerises, which is why a non reducing gel is sometimes run beside the standard one.

A caspase 9 antibody and the initiator it reports

Initiator and executioner caspases answer different questions, and both are read as cleavage rather than as level. A caspase 9 antibody should state whether it detects the procaspase, the cleaved fragments or both, and the expected masses belong in the method. Because cleavage is rapid and partial, a time course rather than a single point is what shows the pathway ran.

Common questions

Why is my caspase blot negative when the cells clearly died?

Frequently because the dying cells detached and were washed away before lysis, or because the timepoint sat after the peak. Collect the supernatant cells and run a time course before concluding the pathway was not involved.

Total or cleaved reagents, and where does a PARP1 antibody fit?

Cleaved for the question of whether death occurred, total as the loading reference. Buying only the total reagent is the commonest way to end up with a blot that cannot answer the question asked of it.

Is a survival protein level meaningful on its own?

Rarely. It sets a threshold that only means something relative to the sensitisers present. Report both, and treat any single value as descriptive rather than mechanistic.

Browse by service class

• Compare Gene synthesis on advertised prices